Enhancement of anti-murine colon cancer immunity by fusion of a SARS fragment to a low-immunogenic carcinoembryonic antigen
<p>Abstract</p> <p>Background</p> <p>It is widely understood that tumor cells express tumor-associated antigens (TAAs), of which many are usually in low immunogenicity; for example, carcinoembryonic antigen (CEA) is specifically expressed on human colon cancer cells and...
Main Authors: | Lin Chen-Si, Kao Shih-Han, Chen Yu-Cheng, Li Chi-Han, Hsieh Yuan-Ting, Yang Shang-Chih, Wu Chang-Jer, Lee Ru-Ping, Liao Kuang-Wen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-02-01
|
Series: | Biological Procedures Online |
Subjects: | |
Online Access: | http://www.biologicalproceduresonline.com/content/14/1/2 |
Similar Items
-
LncRNA FENDRR Expression Correlates with Tumor Immunogenicity
by: Maria Cristina Munteanu, et al.
Published: (2021-06-01) -
Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction
by: Shixiang Wang, et al.
Published: (2019-11-01) -
Exploiting the immunogenic potential of cancer cells for improved dendritic cell vaccines
by: Lien eVandenberk, et al.
Published: (2016-01-01) -
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
by: Abhishek D Garg, et al.
Published: (2015-11-01) -
Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors
by: Qi J, et al.
Published: (2021-02-01)